CNY 13.0
(1.17%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 3.66 Million CNY | -92.86% |
2022 | 51.32 Million CNY | 3461.45% |
2021 | 1.44 Million CNY | 0.0% |
2020 | - CNY | -100.0% |
2019 | 147.02 Thousand CNY | 0.0% |
2018 | - CNY | 0.0% |
2017 | - CNY | -100.0% |
2016 | 85 Million CNY | -44.98% |
2015 | 154.5 Million CNY | 3333.33% |
2014 | 4.5 Million CNY | 0.0% |
2013 | - CNY | 0.0% |
2012 | - CNY | 0.0% |
2011 | - CNY | 0.0% |
2010 | - CNY | 0.0% |
2009 | - CNY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 4.4 Million CNY | 100.0% |
2024 Q3 | 901.27 Thousand CNY | 0.0% |
2024 Q2 | 1.32 Million CNY | 0.0% |
2023 Q4 | 3.66 Million CNY | -93.11% |
2023 Q3 | 53.25 Million CNY | -5.15% |
2023 FY | 3.66 Million CNY | -92.86% |
2023 Q1 | 51.28 Million CNY | -0.08% |
2023 Q2 | 56.15 Million CNY | 9.49% |
2022 FY | 51.32 Million CNY | 3461.45% |
2022 Q1 | 598.45 Thousand CNY | -58.48% |
2022 Q4 | 51.32 Million CNY | 0.0% |
2022 Q3 | - CNY | 0.0% |
2022 Q2 | - CNY | -100.0% |
2021 FY | 1.44 Million CNY | 0.0% |
2021 Q1 | - CNY | 0.0% |
2021 Q2 | - CNY | 0.0% |
2021 Q3 | 2.27 Million CNY | 0.0% |
2021 Q4 | 1.44 Million CNY | -36.63% |
2020 Q2 | 80.8 Thousand CNY | -45.04% |
2020 Q3 | 1.00 CNY | -100.0% |
2020 FY | - CNY | -100.0% |
2020 Q1 | 147.02 Thousand CNY | 0.0% |
2020 Q4 | - CNY | -100.0% |
2019 FY | 147.02 Thousand CNY | 0.0% |
2019 Q4 | 147.02 Thousand CNY | 0.0% |
2019 Q3 | - CNY | 0.0% |
2019 Q2 | - CNY | 0.0% |
2019 Q1 | - CNY | 0.0% |
2018 Q1 | 1.00 CNY | 0.0% |
2018 FY | - CNY | 0.0% |
2018 Q4 | - CNY | -100.0% |
2018 Q3 | - CNY | 0.0% |
2018 Q2 | - CNY | -100.0% |
2017 Q3 | 42.5 Million CNY | 0.0% |
2017 Q4 | - CNY | -100.0% |
2017 FY | - CNY | -100.0% |
2017 Q1 | 50 Million CNY | -41.18% |
2017 Q2 | 42.5 Million CNY | -15.0% |
2016 Q1 | 154.5 Million CNY | 0.0% |
2016 FY | 85 Million CNY | -44.98% |
2016 Q4 | 85 Million CNY | -30.33% |
2016 Q3 | 122 Million CNY | 0.0% |
2016 Q2 | 122 Million CNY | -21.04% |
2015 Q4 | 154.5 Million CNY | 3333.33% |
2015 Q2 | 4.5 Million CNY | 0.0% |
2015 Q1 | 4.5 Million CNY | 0.0% |
2015 FY | 154.5 Million CNY | 3333.33% |
2015 Q3 | 4.5 Million CNY | 0.0% |
2014 Q2 | - CNY | 0.0% |
2014 Q1 | - CNY | 0.0% |
2014 FY | 4.5 Million CNY | 0.0% |
2014 Q4 | 4.5 Million CNY | 0.0% |
2014 Q3 | - CNY | 0.0% |
2013 FY | - CNY | 0.0% |
2013 Q4 | - CNY | 0.0% |
2012 FY | - CNY | 0.0% |
2011 FY | - CNY | 0.0% |
2010 FY | - CNY | 0.0% |
2009 FY | - CNY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Dian Diagnostics Group Co.,Ltd. | 2.33 Billion CNY | 99.843% |
Hangzhou Tigermed Consulting Co., Ltd. | 434.22 Million CNY | 99.156% |
Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | 99.676% |
Medicalsystem Biotechnology Co., Ltd. | 23.59 Million CNY | 84.459% |
Maccura Biotechnology Co.Ltd | 175.47 Million CNY | 97.91% |
Guangzhou Wondfo Biotech Co.,Ltd | 580.52 Million CNY | 99.368% |
Guangdong Hybribio Biotech Co.,Ltd. | 28.26 Million CNY | 87.028% |
BGI Genomics Co., Ltd. | 283.42 Million CNY | 98.706% |
Amoy Diagnostics Co., Ltd. | 44.4 Million CNY | 91.741% |
Shanghai Labway Clinical Laboratory Co., Ltd. | 166.83 Million CNY | 97.802% |